Home

Loading...

Table of contents

Perioperative cardiac risk management for noncardiac surgery

What's new

Added 2023 ESVS, 2023 ESAIC, 2022 ESC, 2022 ACC/AHA/SCAI, 2022 ACCP, and 2016 CCS guidelines for perioperative cardiac risk management for noncardiac surgery.

Guidelines

Key sources

The following summarized guidelines for the evaluation and management of perioperative cardiac risk management for noncardiac surgery are prepared by our editorial team based on guidelines from the European Society for Vascular Surgery (ESVS 2023), the European Society of Anaesthesiology and Intensive Care (ESAIC 2023), the European Society of Cardiology (ESC 2023,2022,2021), the American College of Chest Physicians (ACCP 2022), ...
Show more

Classification and risk stratification

Cardiac risk stratification: as per ESC 2022 guidelines, obtain preoperative risk assessment, ideally at the same time as the NCS is proposed.
B
Create free account

Diagnostic investigations

History and physical examination: as per ESC 2022 guidelines, elicit an accurate history and obtain a clinical assessment in all patients scheduled for NCS.
B
Show 3 more

More topics in this section

  • ECG (low-risk patients)

  • ECG (high-risk patients)

  • Cardiac biomarkers

  • Echocardiography

  • Exercise stress testing

  • Pharmacological stress testing

  • Coronary CTA

  • Hemoglobin levels

Diagnostic procedures

Coronary angiography: as per ESC 2022 guidelines, use the same indications for invasive coronary angiography and revascularization preoperatively as in the non-surgical setting.
B
Show 2 more

Medical management

General principles: as per ESC 2022 guidelines, optimize guideline-recommended treatment of CVD and cardiovascular risk factors before NCS if time allows.
B
control cardiovascular risk factors, including BP, dyslipidemia, and diabetes, before NCS.
B

More topics in this section

  • Management of beta-blockers

  • Management of RAAS inhibitors

  • Management of statins

  • Management of antiplatelets

  • Management of anticoagulants (VKAs, elective surgeries/procedures)

  • Management of anticoagulants (VKAs, minor procedures)

  • Management of anticoagulants (heparins)

  • Management of anticoagulants (DOACs)

  • Management of diuretics

  • Management of SGLT-2 inhibitors

  • Prophylactic beta-blockers

  • Prophylactic alpha-2 agonists

  • Prophylactic CCBs

  • Prophylactic statins

  • Prophylactic aspirin

  • Prophylactic nitroglycerin

Nonpharmacologic interventions

Smoking cessation: as per ESC 2022 guidelines, advise smoking cessation > 4 weeks before NCS to reduce postoperative complications and mortality.
B

Therapeutic procedures

Coronary revascularization: as per ESC 2022 guidelines, consider obtaining preoperative evaluation in patients with an indication for PCI by an expert team (surgeon and cardiologist) before elective NCS.
C
Show 3 more

More topics in this section

  • Pulmonary artery catheterization

  • Hemodynamic assist devices

Perioperative care

Choice of anesthesia: as per ACC/AHA 2014 guidelines, consider administering either a volatile anesthetic agent or total IV anesthesia in patients undergoing NCS, with the choice determined by factors other than the prevention of myocardial ischemia and myocardial infarction.
B

More topics in this section

  • Hemodynamic monitoring

  • BP control

  • Body temperature control

  • Thromboprophylaxis

  • Bleeding control

  • Pain management

Surgical interventions

Choice of surgical approach: as per ESC 2022 guidelines, consider using endovascular or video-assisted approaches in patients with high cardiovascular risk undergoing vascular or pulmonary surgery.
C

Specific circumstances

Patients with obesity
As per ESC 2022 guidelines:
Assess cardiorespiratory fitness to estimate perioperative cardiovascular risk in patients with obesity, with particular attention to patients undergoing intermediate- and high-risk NCS.
B
Consider obtaining additional specialist assessment before major elective NCS in patients at high risk of obesity hypoventilation syndrome.
C

More topics in this section

  • Patients with diabetes mellitus

  • Patients with renal impairment

  • Patients with AAA

  • Patients with carotid artery disease (preoperative evaluation)

  • Patients with carotid artery disease (timing of surgery)

  • Patients with carotid artery disease (preoperative statins and antithrombotics)

  • Patients with carotid artery disease (carotid revascularization)

  • Patients with PAD

  • Patients with valvular heart disease (general principles)

  • Patients with valvular heart disease (aortic stenosis)

  • Patients with valvular heart disease (MS)

  • Patients with valvular heart disease (aortic regurgitation)

  • Patients with valvular heart disease (MR)

  • Patients with cardiomyopathy

  • Patients with ACS

  • Patients after PCI

  • Patients with supraventricular arrhythmias

  • Patients with ventricular arrhythmias

  • Patients with cardiac implantable electronic devices

  • Patients with pericardial diseases

  • Patients with adult congenital heart disease

  • Patients with patent foramen ovale

  • Patients with pulmonary hypertension

Patient education

General counseling
As per ESC 2022 guidelines:
Provide patients with individualized instructions for preoperative and postoperative changes in medications, in verbal and written formats with clear and concise directions.
B
Consider providing a structured information list (such as a checklist to help with common issues) in patients with CVD or at high risk of cardiovascular complications scheduled for NCS.
C

Follow-up and surveillance

Postoperative cardiac monitoring, general principles
As per ESC 2022 guidelines:
Ensure high awareness of perioperative cardiovascular complications and obtain surveillance for perioperative myocardial infarction in patients undergoing intermediate- or high-risk NCS.
B
Obtain systematic perioperative myocardial infarction evaluation to identify the underlying pathophysiology and define therapy.
B

More topics in this section

  • Postoperative cardiac monitoring (ECG)

  • Postoperative cardiac monitoring (troponin)

  • Management of postoperative complications (myocardial injury/ischemia)

  • Management of postoperative complications (arrhythmias)

  • Management of postoperative complications (PE)